Global and United States Hepatitis C Drugs Market Size, Status and Forecast 2020-2026
SKU ID : QYR-16359460 | Publishing Date : 02-Sep-2020 | No. of pages : 99
Detailed TOC of Global and United States Hepatitis C Drugs Market Size, Status and Forecast 2020-2026
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Anti-Viral
1.2.3 Immuno-modulators
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hepatitis C Drugs Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis C Drugs Market Perspective (2015-2026)
2.2 Global Hepatitis C Drugs Growth Trends by Regions
2.2.1 Hepatitis C Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hepatitis C Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Hepatitis C Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Drugs Players by Market Size
3.1.1 Global Top Hepatitis C Drugs Players by Revenue (2015-2020)
3.1.2 Global Hepatitis C Drugs Revenue Market Share by Players (2015-2020)
3.2 Global Hepatitis C Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis C Drugs Revenue
3.4 Global Hepatitis C Drugs Market Concentration Ratio
3.4.1 Global Hepatitis C Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Drugs Revenue in 2019
3.5 Key Players Hepatitis C Drugs Area Served
3.6 Key Players Hepatitis C Drugs Product Solution and Service
3.7 Date of Enter into Hepatitis C Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis C Drugs Breakdown Data by Type (2015-2026)
4.1 Global Hepatitis C Drugs Historic Market Size by Type (2015-2020)
4.2 Global Hepatitis C Drugs Forecasted Market Size by Type (2021-2026)
5 Hepatitis C Drugs Breakdown Data by Application (2015-2026)
5.1 Global Hepatitis C Drugs Historic Market Size by Application (2015-2020)
5.2 Global Hepatitis C Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hepatitis C Drugs Market Size (2015-2026)
6.2 North America Hepatitis C Drugs Market Size by Type (2015-2020)
6.3 North America Hepatitis C Drugs Market Size by Application (2015-2020)
6.4 North America Hepatitis C Drugs Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Hepatitis C Drugs Market Size (2015-2026)
7.2 Europe Hepatitis C Drugs Market Size by Type (2015-2020)
7.3 Europe Hepatitis C Drugs Market Size by Application (2015-2020)
7.4 Europe Hepatitis C Drugs Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Hepatitis C Drugs Market Size (2015-2026)
8.2 China Hepatitis C Drugs Market Size by Type (2015-2020)
8.3 China Hepatitis C Drugs Market Size by Application (2015-2020)
8.4 China Hepatitis C Drugs Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Hepatitis C Drugs Market Size (2015-2026)
9.2 Japan Hepatitis C Drugs Market Size by Type (2015-2020)
9.3 Japan Hepatitis C Drugs Market Size by Application (2015-2020)
9.4 Japan Hepatitis C Drugs Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Hepatitis C Drugs Market Size (2015-2026)
10.2 Southeast Asia Hepatitis C Drugs Market Size by Type (2015-2020)
10.3 Southeast Asia Hepatitis C Drugs Market Size by Application (2015-2020)
10.4 Southeast Asia Hepatitis C Drugs Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Gilead sciences
11.1.1 Gilead sciences Company Details
11.1.2 Gilead sciences Business Overview
11.1.3 Gilead sciences Hepatitis C Drugs Introduction
11.1.4 Gilead sciences Revenue in Hepatitis C Drugs Business (2015-2020))
11.1.5 Gilead sciences Recent Development
11.2 Abbvi
11.2.1 Abbvi Company Details
11.2.2 Abbvi Business Overview
11.2.3 Abbvi Hepatitis C Drugs Introduction
11.2.4 Abbvi Revenue in Hepatitis C Drugs Business (2015-2020)
11.2.5 Abbvi Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Hepatitis C Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Hepatitis C Drugs Business (2015-2020)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Hepatitis C Drugs Introduction
11.4.4 Merck Revenue in Hepatitis C Drugs Business (2015-2020)
11.4.5 Merck Recent Development
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Details
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline Hepatitis C Drugs Introduction
11.5.4 Glaxosmithkline Revenue in Hepatitis C Drugs Business (2015-2020)
11.5.5 Glaxosmithkline Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Hepatitis C Drugs Introduction
11.6.4 Novartis Revenue in Hepatitis C Drugs Business (2015-2020)
11.6.5 Novartis Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Hepatitis C Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Hepatitis C Drugs Business (2015-2020)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Hepatitis C Drugs Introduction
11.8.4 Roche Revenue in Hepatitis C Drugs Business (2015-2020)
11.8.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and United States Hepatitis C Drugs Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Global Hepatitis C Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Anti-Viral
Table 4. Key Players of Immuno-modulators
Table 5. Key Players of Others
Table 6. Global Hepatitis C Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Hepatitis C Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Hepatitis C Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Hepatitis C Drugs Market Share by Regions (2015-2020)
Table 10. Global Hepatitis C Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Hepatitis C Drugs Market Share by Regions (2021-2026)
Table 12. Hepatitis C Drugs Market Market Trends
Table 13. Hepatitis C Drugs Market Drivers
Table 14. Hepatitis C Drugs Market Challenges
Table 15. Hepatitis C Drugs Market Restraints
Table 16. Global Hepatitis C Drugs Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Hepatitis C Drugs Market Share by Players (2015-2020)
Table 18. Global Top Hepatitis C Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Drugs as of 2019)
Table 19. Global Hepatitis C Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hepatitis C Drugs Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hepatitis C Drugs Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Hepatitis C Drugs Market Size Share by Type (2015-2020)
Table 25. Global Hepatitis C Drugs Revenue Market Share by Type (2021-2026)
Table 26. Global Hepatitis C Drugs Market Size Share by Application (2015-2020)
Table 27. Global Hepatitis C Drugs Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Hepatitis C Drugs Market Size Share by Application (2021-2026)
Table 29. North America Hepatitis C Drugs Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Hepatitis C Drugs Market Share by Type (2015-2020)
Table 31. North America Hepatitis C Drugs Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Hepatitis C Drugs Market Share by Application (2015-2020)
Table 33. North America Hepatitis C Drugs Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Hepatitis C Drugs Market Share by Country (2015-2020)
Table 35. Europe Hepatitis C Drugs Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Hepatitis C Drugs Market Share by Type (2015-2020)
Table 37. Europe Hepatitis C Drugs Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Hepatitis C Drugs Market Share by Application (2015-2020)
Table 39. Europe Hepatitis C Drugs Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Hepatitis C Drugs Market Share by Country (2015-2020)
Table 41. China Hepatitis C Drugs Market Size by Type (2015-2020) (US$ Million)
Table 42. China Hepatitis C Drugs Market Share by Type (2015-2020)
Table 43. China Hepatitis C Drugs Market Size by Application (2015-2020) (US$ Million)
Table 44. China Hepatitis C Drugs Market Share by Application (2015-2020)
Table 45. China Hepatitis C Drugs Market Size by Region (US$ Million) (2015-2020)
Table 46. China Hepatitis C Drugs Market Share by Region (2015-2020)
Table 47. Japan Hepatitis C Drugs Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Hepatitis C Drugs Market Share by Type (2015-2020)
Table 49. Japan Hepatitis C Drugs Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Hepatitis C Drugs Market Share by Application (2015-2020)
Table 51. Japan Hepatitis C Drugs Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Hepatitis C Drugs Market Share by Country (2015-2020)
Table 53. Southeast Asia Hepatitis C Drugs Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Hepatitis C Drugs Market Share by Type (2015-2020)
Table 55. Southeast Asia Hepatitis C Drugs Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Hepatitis C Drugs Market Share by Application (2015-2020)
Table 57. Southeast Asia Hepatitis C Drugs Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Hepatitis C Drugs Market Share by Country (2015-2020)
Table 59. Gilead sciences Company Details
Table 60. Gilead sciences Business Overview
Table 61. Gilead sciences Product
Table 62. Gilead sciences Revenue in Hepatitis C Drugs Business (2015-2020) (US$ Million)
Table 63. Gilead sciences Recent Development
Table 64. Abbvi Company Details
Table 65. Abbvi Business Overview
Table 66. Abbvi Product
Table 67. Abbvi Revenue in Hepatitis C Drugs Business (2015-2020) (US$ Million)
Table 68. Abbvi Recent Development
Table 69. Johnson & Johnson Company Details
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Product
Table 72. Johnson & Johnson Revenue in Hepatitis C Drugs Business (2015-2020) (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Product
Table 77. Merck Revenue in Hepatitis C Drugs Business (2015-2020) (US$ Million)
Table 78. Merck Recent Development
Table 79. Glaxosmithkline Company Details
Table 80. Glaxosmithkline Business Overview
Table 81. Glaxosmithkline Product
Table 82. Glaxosmithkline Revenue in Hepatitis C Drugs Business (2015-2020) (US$ Million)
Table 83. Glaxosmithkline Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Hepatitis C Drugs Business (2015-2020) (US$ Million)
Table 88. Novartis Recent Development
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Product
Table 92. Bristol-Myers Squibb Revenue in Hepatitis C Drugs Business (2015-2020) (US$ Million)
Table 93. Bristol-Myers Squibb Recent Development
Table 94. Roche Business Overview
Table 95. Roche Product
Table 96. Roche Company Details
Table 97. Roche Revenue in Hepatitis C Drugs Business (2015-2020) (US$ Million)
Table 98. Roche Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis C Drugs Market Share by Type: 2020 VS 2026
Figure 2. Anti-Viral Features
Figure 3. Immuno-modulators Features
Figure 4. Others Features
Figure 5. Global Hepatitis C Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Hepatitis C Drugs Report Years Considered
Figure 9. Global Hepatitis C Drugs Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Hepatitis C Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Hepatitis C Drugs Market Share by Regions (2021-2026)
Figure 12. Global Hepatitis C Drugs Market Share by Players in 2019
Figure 13. Global Top Hepatitis C Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Drugs as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Hepatitis C Drugs Revenue in 2019
Figure 15. North America Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Hepatitis C Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Gilead sciences Revenue Growth Rate in Hepatitis C Drugs Business (2015-2020)
Figure 43. Abbvi Revenue Growth Rate in Hepatitis C Drugs Business (2015-2020)
Figure 44. Johnson & Johnson Revenue Growth Rate in Hepatitis C Drugs Business (2015-2020)
Figure 45. Merck Revenue Growth Rate in Hepatitis C Drugs Business (2015-2020)
Figure 46. Glaxosmithkline Revenue Growth Rate in Hepatitis C Drugs Business (2015-2020)
Figure 47. Novartis Revenue Growth Rate in Hepatitis C Drugs Business (2015-2020)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis C Drugs Business (2015-2020)
Figure 49. Roche Revenue Growth Rate in Hepatitis C Drugs Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Keyplayers in Global and United States Hepatitis C Drugs Market Size, Status and Forecast 2020-2026
Gilead sciencesAbbvi
Johnson & Johnson
Merck
Glaxosmithkline
Novartis
Bristol-Myers Squibb
Roche